As machineMD expands its clinical research and evidence generation for neos^®, we’re thrilled to welcome two new Clinical Affairs Managers, Melina Maamir and Ilona Hubbard.

Both bring rich clinical...

machineMD is an implementation partner in the new dementia-focused SwissBrAInHealth Flagship Initiative supported by Innosuisse. The transdisciplinary project will contribute to the development of...

machineMD has been granted an InnoCheque funding by Innosuisse for its collaboration with the FHNW University of Applied Sciences and Arts Northwestern Switzerland. The objective is to demonstrate in...

Bern, Switzerland & San Diego, USA  – machineMD, an award-winning medical device company at the forefront of neurodiagnostic innovation, today announced a strategic investment from Topcon Healthcare,

MATTER, the premier healthcare incubator and innovation hub, with support from theLundbeck US Charitable Fund, a corporate foundation dedicated to responsibly giving back to the community, has...

A recent study by Ana Coito PhD, Avantika Naidu PhD, Julian Lehmann MS, Bruno Hauser MS, Dominik Brügger PhD, and Mathias Abegg MD PhD evaluated the test-retest reliability of gaze precision of neos®...

Automated Measurement of Strabismus Angle Using a Commercial Virtual Reality Headset

Current clinical measurements of strabismus angles (SAs) are manual and require a skilled examiner and active...

Use of a Novel Virtual Reality-Based Pupillography Device for Glaucoma Management: Cross-Sectional Cohort Pilot Study

Background: Current standard methods in monitoring glaucoma progression, like...

Zurich is home to ebovis, the world's first ophthalmology practice to offer a standardized, complete, apparative eye examination. The neos™ examination device developed by machineMD, the world's...